GSTM1 and anemia: Using the WHO Hb cut-offs, anaemia prevalence reduced to 0.4% in males and overall prevalence to 4.7% which is quite low compared to the estimated global prevalence of 12.7% and 29.0% for males (15–60 years) and non-pregnant females (15–49 years) respectively [1,16].